A new stem-cell treatment may help heart attack patients do something once thought medically impossible — regenerate dead heart muscle.
Richard Schatz, MD, is leading the Allstar study at Scripps Clinic — it is just one of three centers in the nation testing the therapy from Capricor, a Los Angeles biotech company. The cardiac stem cells are meant to boost the heart’s natural ability to perform minor repairs. If it works, scars should shrink and functional heart muscle should grow.
The article about the Allstar trial in the U-T San Diego, "Mending a Broken Heart with Stem Cells," is not available at this time.